GW Pharmaceuticals PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GW Pharmaceuticals PLC with three other
companies in this sector in the United States:
Bioanalytical Systems, Inc.
sales of $26.35 million
of which 53%
was Milestone Payments), and
of which 100%
was Pharmaceuticals preparation).
Sales increased substantially in 2018:
GW Pharmaceuticals PLC reported sales of $26.62 million
December of 2018.
increase of 153.4%
versus 2017, when the company's sales were $10.50 million.